Evaristus Nwulia, M.D. MHS, is a Johns Hopkins trained physician and a neuroscientist, with over 15 years history in leading educational and training programs aimed at enhancing representation of underrepresented minority STEM and MD-Ph.D. students from HBCUs in the neuroscience workforce. He is also a Professor of Neuroscience at Howard University, who pioneered the development of home-based olfactory sensory stimulation platforms as disease modifying interventions for early Alzheimer’s disease. He holds several patents for devices and drugs, and for olfactory transcellular drug delivery methods for CNS disorders. He is co-Founder of three neuromedical device companies, including Evon Medics LLC, a neuroTech company tackling neurodegenerative diseases, traumatic brain injuries and chronic pain; with over 65% employees from URM populations, Evon Medics has become a harbor for nurturing career development of highly talented young minority innovators. Evaristus has been a member of several NIH neuroscience-based scientific peer review panels over the past 10 years and has chaired the NIH Fogarty Global Brain Disorders Special Emphasis Panel. Ergo, he has extensive experience for recognition of projects with potential transformative impact. As a Neuroethicist and Chair of the Institutional Ethics Committee Board at Howard University, he brings substantial expertise in the ethical, legal, and societal implications of neuroscience and neurotech devices, particularly from the standpoint of several under-represented minority populations.